MedTwin: Digital Twins and AI for Personalized Cancer Care
Turning clinical data into safer, smarter, and more personalized decisions
Transforming Oncology with AI-Powered Digital Twins
MedTwin is an advanced platform that combines Multimodal Digital Twins and Generative AI to empower oncology teams with predictive, personalized, and data-driven clinical decisions.
Developed for forward-thinking hospitals and healthcare providers, MedTwin simulates clinical scenarios, anticipates risks, and enhances treatment planning — all tailored to the individual patient.
What MedTwin Delivers
-
Patient Digital Twin
A dynamic, real-time replica of the patient, integrating clinical records, imaging, genomics, and lifestyle data. -
Generative and Explainable AI
Transparent, evidence-based decision support — always explainable, always grounded in clinical science. -
Virtual Clinical Simulations
Test therapeutic approaches virtually before applying them in real life — safer for patients, smarter for clinicians. -
Secure & Interoperable Architecture
Full integration with HIS, PACS, and CRM systems. Built for privacy, security, and scalability. -
Specialized Modules
Custom components for specific cancer types, clinical workflows, and institutional protocols.


MedTwin is ideal for:
-
Private Hospitals
Ready to lead in digital oncology and patient-centric care. -
Cancer Care Groups
Seeking greater precision and better outcomes with AI-powered decisions. -
Institutional Partners
Adopting next-gen tools to enhance clinical decision-making. -
Strategic Investors
Focused on scalable, high-impact healthtech.
Priority Use Cases
-
Lung Cancer & Pulmonary Nodule Management
-
Personalized Radiotherapy Planning
-
Biomarker Discovery & Virtual Trials
-
Simulated Patient Journeys & Longitudinal Monitoring
Your Institution can benefit today.
MedTwin is now available for early-stage clinical pilot projects and custom deployments — co-developed and supported by our expert team of data scientists, clinicians, and digital health specialists. Be part of shaping the future of cancer care with cutting-edge AI and digital twin technology, adapted and refined in real-world environments.
Contact us